Trevi Therapeutics Inc TRVI
News
Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024
Trevi Therapeutics to Participate in September Investor and Medical Conferences
Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance
Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events